SUMELIA WADDELL: Open Payments
NPI 1710594114 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 31 payments from 11 companies in 2025. Trend: 2023 $300 · 2024 $428 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $201 |
| Novo Nordisk Inc | 5 | $158 |
| Janssen Biotech, Inc. | 5 | $117 |
| CVRx, Inc. | 2 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Amgen Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $30 |
| Ardelyx, Inc. | 1 | $28 |
| Vital Connect, Inc | 1 | $18 |
Products named: LEQVIO, Wegovy, TECVAYLI, Barostim Neo System, CAMZYOS, REPATHA, Ozempic, ONPATTRO.
Industry payments across FL — which companies pay providers there.
